Marie anticorps SIGMAMAB (ADC)

Code: msqc8-0.5mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Poster: Antibody Drug Conjugate Mimic Enables LC-MS Method Development Without RiskPoster: LC-UV-MS Method Development for Antibody Drug Conjugates Using a Non-To...


en savoir plus

Votre prix
£637.00 EACH
£764.40 inc. VAT

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Poster: Antibody Drug Conjugate Mimic Enables LC-MS Method Development Without RiskPoster: LC-UV-MS Method Development for Antibody Drug Conjugates Using a Non-Toxic ADC-MimicPoster: LC-MS Method Development for Antibody Drug Conjugates Using a Non-Toxic ADC Mimic

General description

SigmaMab Antibody Drug Conjugate (ADC) Mimic, is a non-toxic drug mimic that is utilized as a standard for mass spectrometry and high performance liquid chromatography. The ADC Mimic conjugates SigmaMab (MSQC4), an IgG1 monoclonal antibody, to dansyl fluorophores via an LC-SMCC crosslinker. This dansyl-LC-SMCC attachment serves as the substitution for the toxic payload of a real ADC. The ADC Mimic allows for safer and more consistent testing, making it the optimal product over real ADCs. It is also a more affordable product compared to real ADCs. With the help of this non-toxic product, LC-MS processes can be developed in a safer environment.

antibody product typeprimary antibodies
formlyophilized powder
Quality Level200
recombinantexpressed in CHO cells
shipped inwet ice
storage temp.−20°C
Ce produit répond aux critères suivants: